Isoginkgetin Inhibits RANKL-induced Osteoclastogenesis and Alleviates Bone Loss
{{output}}
Osteoporosis is characterized by excessive osteoclast activity leading to bone loss, decreased bone mineral density, and increased susceptibility to fractures. Through in vivo/vitro experiments, along with network pharmacology analysis, we aimed to explore the... ...